Hemostatic and fibrinolytic effects of systemic prostaglandin E1 therapy in patients with peripheral arterial disease.

Kuss, M

Hemostatic and fibrinolytic effects of systemic prostaglandin E1 therapy in patients with peripheral arterial disease. [electronic resource] - VASA. Zeitschrift fur Gefasskrankheiten Aug 2003 - 145-8 p. digital

Publication Type: Journal Article

0301-1526

10.1024/0301-1526.32.3.145 doi


Aged
Aged, 80 and over
Alprostadil--administration & dosage
Arterial Occlusive Diseases--blood
Blood Coagulation Factors--metabolism
Blood Coagulation Tests
Female
Fibrinolysis--drug effects
Fibrinolytic Agents--adverse effects
Hemorrhage--blood
Hemostasis--drug effects
Humans
Infusions, Intravenous
Male
Middle Aged
Risk Assessment